₹1006.9
Day's Low
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 10.2 % |
3 Month Return | + 12.12 % |
1 Year Return | + 20.63 % |
Market Stats | |
Previous Close | ₹1,021.00 |
Open | ₹995.00 |
Volume | 3,005.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹117.83Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹117.83 Cr |
P/B Ratio | 1.54 |
EPS | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
![]() | NA | ₹117.83 Cr | 58.3% | 0.57 | NA | NA |
![]() | BUY | ₹24,251.56 Cr | 13.4% | 0.53 | NA | NA |
![]() | NA | ₹531.11 Cr | 229.99% | 0.66 | ₹19 Cr | ₹251 Cr |
![]() | BUY | ₹10,461.37 Cr | 2.81% | 0.50 | NA | NA |
![]() | NA | ₹1,037.27 Cr | 301.68% | 0.64 | ₹10 Cr | ₹64 Cr |
Organisation | Mercury Laboratories Ltd |
Headquarters | Vadodara |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, Mercury Labs stock has moved up by 15.4%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 26.34% of holdings in Jun 2024 quarter
Against Peers
In the last 1 year, Zydus Lifesciences Ltd has given 87.2% return, outperforming this stock by 56.7%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 73.66% of holdings in Jun 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 127.7% return, outperforming this stock by 90.8%
2023 | Y/Y Change | |
---|---|---|
Total Assets | ₹67.99Cr | ↑8.35% |
Total Liabilities | ₹22.36Cr | ↓0.36% |
2023 | Y/Y Change | |
---|---|---|
Operating Cash Flow | ₹2.45Cr | ↓52.79% |
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 73.66% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 26.34% | 0.00 | |
Others | 0% | 0.00 |
Mercury Laboratories Ltd’s net profit fell -66% since last year same period to ₹0.34Cr in the Q1 2024-2025. On a quarterly growth basis, Mercury Laboratories Ltd has generated -82.2% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2023, Mercury Laboratories Ltd has declared dividend of ₹3.50 - translating a dividend yield of 0.70%.
Read More about DividendsBearish
Neutral
Bullish
Mercury Laboratories Ltd is currently in a Bullish trading position according to technical analysis indicators.
Mercury Laboratories Ltd (538964) share price today is ₹1006.9
Mercury Laboratories Ltd is not listed on NSE
Mercury Laboratories Ltd is listed on BSE
Today’s traded volume of Mercury Laboratories Ltd(538964) is 3,005.00.
Today’s market capitalisation of Mercury Laboratories Ltd(538964) is ₹117.83Cr.
Mercury Laboratories Ltd(538964 | Price |
---|---|
52 Week High | ₹1303 |
52 Week Low | ₹709 |
Mercury Laboratories Ltd(538964) share price is ₹1006.9. It is down -22.72% from its 52 Week High price of ₹1303
Mercury Laboratories Ltd(538964) share price is ₹1006.9. It is up 42.02% from its 52 Week Low price of ₹709
Mercury Laboratories Ltd(538964 | Returns |
---|---|
1 Day Returns | -14.1% |
1 Month Returns | 10.2% |
3 Month Returns | 12.12% |
1 Year Returns | 20.63% |